Graves’ hyperthyroidism (hyperthyroidism for short) is a common and frequent clinical disease, and its incidence is on the rise in China, and its standardized diagnosis and treatment is directly related to the clinical efficacy. At present, there are three main clinical treatment methods for Graves’ hyperthyroidism: medical drug therapy, nuclear medicine “1I” therapy and surgical treatment, among which “1I” therapy has been widely accepted in the United States and other countries because of its advantages of quick and easy, high quality and low cost, few adverse reactions and good therapeutic effect. It has become the treatment of choice or priority for most adult Graves’ hyperthyroidism patients.